INRLF (Valneva SE) Total Payout Yield %: -4.73 (As of Jul. 12, 2026)


INRLF Valneva SE INRLF
55 GF Score
Price $2.62
GF Value $2.69
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Total Payout Yield %?

Valneva SE INRLF 55 Total Payout Yield % is -4.73 as of Jul. 12, 2026. GuruFocus rates INRLF with a GF Score™ of 55/100 and a GF Value™ of $2.69 (Fairly Valued). The stock has 6 warning signs investors should review.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Valneva SE's current Total Payout Yield % is -4.73%.


Valneva SE Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Valneva SE Total Payout Yield % Related Terms


Valneva SE Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for Valneva SE's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Total Payout Yield % Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.52 -22.12 0.04 -17.63 -4.82

Valneva SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -17.63 0.00 0.00 -0.78

INRLF vs VRTX, REGN, ALNY: Total Payout Yield % Comparison

For the Biotechnology subindustry, Valneva SE's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE Total Payout Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Valneva SE's Total Payout Yield % falls into.


INRLF
55GF Score
Valneva SE INRLF
Total Payout Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Valneva SE's Total Payout Yield % for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (35.132 + 0 + 0) / 728.6031225
=-4.82%

Valneva SE's annualized Total Payout Yield % for the quarter that ended in Mar. 2026 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (1.064 + 0 + 0) * 4 / 543.84689
=-0.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of -4.73 mean?
Valneva SE (INRLF) has a Total Payout Yield % of -4.73 as of Jul. 12, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Valneva SE and its competitors.
Is Valneva SE's Total Payout Yield % too high?
Valneva SE's current Total Payout Yield % is -4.73. Overall, Valneva SE has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Total Payout Yield % compare to VRTX and REGN?
Valneva SE's Total Payout Yield % of -4.73 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Biotechnology company?
A good Total Payout Yield % depends on the Biotechnology industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Valneva SE and its competitors. Valneva SE's current Total Payout Yield % is -4.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (INRLF) is currently considered Fairly Valued. The stock's GF Value™ is $2.69, compared to a current price of $2.62 — trading 2.6% below its estimated fair value. The current Total Payout Yield % is -4.73. Valneva SE's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Valneva SE (INRLF), the current Total Payout Yield % is -4.73 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valneva SE (INRLF) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of $2.62 is trading 2.6% below its estimated GF Value™ of $2.69. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for INRLF:

  • Total Payout Yield %: -4.73
  • GF Value™: $2.69 vs. price of $2.62 (2.6% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the INRLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
55GF Score

Get the complete analysis for INRLF

Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.62
Price
$2.69
GF Value